Literature DB >> 26130098

Five-Year Outcome in Stroke Patients Submitted to Thrombolysis.

Célia Machado1, João Pinho2, José Nuno Alves2, Ana Filipa Santos2, Maria do Céu Ferreira2, Maria João Abreu2, Liliana Oliveira2, João Mota2, João Ramalho Fontes2, Carla Ferreira2.   

Abstract

BACKGROUND AND
PURPOSE: Little is known on long-term follow-up after thrombolysis in ischemic stroke patients because the majority of studies evaluated outcome at 3 to 12 months. We aimed to assess 5-year outcome after intravenous thrombolysis (IVT).
METHODS: Cohort study based on the prospective registry of all consecutive ischemic stroke patients submitted to IVT in our Stroke Unit. Five-year outcome, including living settings, functional outcome, stroke recurrence, and mortality, was ascertained by telephonic interviews and additional review of clinical records. Multivariate analyses were performed to identify predictors of outcome and mortality. Excellent outcome was defined as modified Rankin scale 0 to 1.
RESULTS: Five-year outcome was available for 155/164 patients submitted to IVT. At 5 years, 32.9% of patients had an excellent outcome (95% confidence interval (CI) =25.5-43.3) and mortality was 43.9% (95%CI=36.1-51.7). Increasing age (odds ratio =0.93, 95% CI =0.90-0.97) and increasing National Institute of Health Stroke Scale (NIHSS) 24 h after thrombolysis (odds ratio =0.81, 95% CI =0.74-0.90) were independently associated with a lower likelihood of an excellent 5-year outcome. Age (hazards ratio =1.07, 95% CI =1.03-1.11) and excellent functional outcome 3 months after thrombolysis (hazards ratio =0.28, 95%CI=0.12-0.66) were independently associated with mortality during follow-up.
CONCLUSIONS: One third of ischemic stroke patients have excellent 5-year outcome after IVT. Younger age, lower NIHSS 24 h after IVT, and excellent 3-month functional outcome are independent predictors of excellent 5-year outcome.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  mortality; stroke; thrombolytic therapy; treatment outcome

Mesh:

Substances:

Year:  2015        PMID: 26130098     DOI: 10.1161/STROKEAHA.115.009842

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  Predictors of functional outcome in patients with stroke thrombolysis in a tertiary hospital in Malaysia.

Authors:  Mei-Ling Sharon Tai; Khean Jin Goh; Khairul Azmi Abdul Kadir; Mohd Idzwan Zakaria; Jun Fai Yap; Kay Sin Tan
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

2.  Prognostic information of gaze deviation in acute ischemic stroke patients.

Authors:  Ana Lima Silva; Ana Sofia Pessoa; Renato Nogueira; José Manuel Araújo; José Nuno Alves; João Pinho; Carla Ferreira
Journal:  Neurol Sci       Date:  2019-11-11       Impact factor: 3.307

3.  Validation of the mSOAR and SOAR scores to predict early mortality in Chinese acute stroke patients.

Authors:  Hui Wang; Yuesong Pan; Xia Meng; Chunjuan Wang; Xiaoling Liao; David Wang; Xingquan Zhao; Liping Liu; Hao Li; Yilong Wang; Yongjun Wang
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

4.  Long-Term Survival After Intravenous Thrombolysis for Ischemic Stroke: A Propensity Score-Matched Cohort With up to 10-Year Follow-Up.

Authors:  Walter Muruet; Anthony Rudd; Charles D A Wolfe; Abdel Douiri
Journal:  Stroke       Date:  2018-02-12       Impact factor: 7.914

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.